Rankings
▼
Calendar
PRTA Q4 2021 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+225.6% YoY
Gross Profit
-$21M
-1782.1% margin
Operating Income
-$33M
-2823.5% margin
Net Income
-$33M
-2831.0% margin
EPS (Diluted)
$-0.71
QoQ Revenue Growth
-99.2%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$23M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$609M
Total Liabilities
$143M
Stockholders' Equity
$466M
Cash & Equivalents
$579M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$360,000
+225.6%
Gross Profit
-$21M
-$20M
-2.4%
Operating Income
-$33M
-$30M
-9.2%
Net Income
-$33M
-$31M
-8.0%
Revenue Segments
Collaboration
$1M
100%
← FY 2021
All Quarters
Q1 2022 →